2025
SJR Q2
JCR Q2 · 2,9
12 matched articles
SCIE
Journal detail
Alcohol
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0741832918736823
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,697
- Quartile Q2
- H-Index 93
- Cites/doc 2,51
- Docs (3y) 213
- Cites (3y) 535
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 2,5
- JCI 0,75
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Behavioral Neuroscience Q3
- Biochemistry Q2
- Health (social science) Q2
- Medicine (miscellaneous) Q2
- Neurology Q3
- Toxicology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Neuroscience
- Pharmacology, Toxicology and Pharmaceutics
- Social Sciences
WoS categories
- Substance Abuse | Pharmacology & Pharmacy | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,697 | 2,9 | 2,5 | 0,75 | Q2 | 93 |
| 2024 | Q2 | Q2 | 0,704 | 2,9 | 2,5 | 0,86 | Q2 | 90 |
| 2023 | Q2 | Q2 | 0,621 | 2,5 | 2,2 | 0,65 | Q2 | 90 |
| 2022 | Q2 | Q3 | 0,593 | 2,3 | 2,3 | 0,69 | Q2 | 90 |
| 2021 | Q2 | Q3 | 0,566 | 2,6 | 2,6 | 0,72 | Q2 | 90 |
| 2020 | Q2 | Q3 | 0,75 | 2,4 | 2,8 | 0,83 | Q2 | 90 |
| 2019 | Q1 | Q3 | 0,729 | 2,5 | 2,7 | 0,77 | Q2 | 90 |
| 2018 | — | Q3 | — | 2 | 2,5 | 0,9 | Q2 | — |
| 2017 | Q1 | Q3 | 1,153 | 2,4 | 2,4 | 0,96 | Q2 | 90 |
| 2016 | Q1 | Q2 | 1,229 | 2,8 | 2,4 | — | — | 90 |
| 2015 | Q1 | Q2 | 0,934 | 2,4 | 2,3 | — | — | 90 |
| 2014 | Q1 | Q3 | 0,873 | 2 | 2,3 | — | — | 90 |
| 2013 | Q1 | Q3 | 0,996 | 2 | 2,5 | — | — | 90 |
| 2012 | Q1 | Q2 | 0,949 | 2,3 | 2,5 | — | — | 90 |
| 2011 | Q1 | Q2 | 0,95 | 2,5 | 2,4 | — | — | 90 |
| 2010 | Q1 | Q2 | 0,819 | 2,4 | 2,3 | — | — | 90 |
| 2009 | — | Q2 | — | 2,4 | 2,5 | — | — | — |
| 2008 | — | Q2 | — | 2,4 | 2,4 | — | — | — |
| 2007 | — | Q2 | — | 2,1 | 2,3 | — | — | — |
| 2006 | — | Q2 | — | 2 | — | — | — | — |
| 2005 | — | Q2 | — | 1,7 | — | — | — | — |
| 2004 | — | Q2 | — | 1,9 | — | — | — | — |
| 2003 | — | Q2 | — | 1,6 | — | — | — | — |
| 2002 | — | Q2 | — | 1,7 | — | — | — | — |
| 2001 | — | Q2 | — | 1,3 | — | — | — | — |
| 2000 | — | Q2 | — | 1,5 | — | — | — | — |
| 1999 | — | Q2 | — | 1,4 | — | — | — | — |
| 1998 | — | Q2 | — | 1,3 | — | — | — | — |
| 1997 | — | Q2 | — | 1,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 173/356 |
| 2025 | SUBSTANCE ABUSE | SCIE | Q2 | Q3 | 17/61 |
| 2025 | TOXICOLOGY | SCIE | Q3 | Q2 | 57/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 150/352 |
| 2024 | SUBSTANCE ABUSE | SCIE | Q2 | Q2 | 16/58 |
| 2024 | TOXICOLOGY | SCIE | Q2 | Q2 | 49/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 180/354 |
| 2023 | SUBSTANCE ABUSE | SCIE | Q2 | Q3 | 24/56 |
| 2023 | TOXICOLOGY | SCIE | Q3 | Q3 | 65/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 200/278 |
| 2022 | SUBSTANCE ABUSE | SCIE | Q4 | Q3 | 18/21 |
| 2022 | TOXICOLOGY | SCIE | Q4 | Q3 | 71/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 201/279 |
| 2021 | SUBSTANCE ABUSE | SCIE | Q4 | Q2 | 18/21 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q2 | 77/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 203/276 |
| 2020 | SUBSTANCE ABUSE | SCIE | Q4 | Q2 | 18/21 |
| 2020 | TOXICOLOGY | SCIE | Q4 | Q2 | 75/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 156/271 |
| 2019 | SUBSTANCE ABUSE | SCIE | Q3 | Q2 | 12/20 |
| 2019 | TOXICOLOGY | SCIE | Q3 | Q3 | 55/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 180/267 |
| 2018 | SUBSTANCE ABUSE | SCIE | Q3 | Q2 | 13/19 |
| 2018 | TOXICOLOGY | SCIE | Q3 | Q2 | 69/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 134/261 |
| 2017 | SUBSTANCE ABUSE | SCIE | Q3 | Q2 | 10/19 |
| 2017 | TOXICOLOGY | SCIE | Q3 | Q2 | 49/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 104/257 |
| 2016 | SUBSTANCE ABUSE | SCIE | Q2 | — | 6/18 |
| 2016 | TOXICOLOGY | SCIE | Q2 | — | 35/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 119/255 |
| 2015 | SUBSTANCE ABUSE | SCIE | Q2 | — | 9/18 |
| 2015 | TOXICOLOGY | SCIE | Q2 | — | 39/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 149/255 |
| 2014 | SUBSTANCE ABUSE | SCIE | Q3 | — | 11/18 |
| 2014 | TOXICOLOGY | SCIE | Q3 | — | 57/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 148/256 |
| 2013 | SUBSTANCE ABUSE | SCIE | Q3 | — | 10/18 |
| 2013 | TOXICOLOGY | SCIE | Q3 | — | 54/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 125/261 |
| 2012 | SUBSTANCE ABUSE | SCIE | Q2 | — | 7/16 |
| 2012 | TOXICOLOGY | SCIE | Q2 | — | 42/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 112/261 |
| 2011 | SUBSTANCE ABUSE | SCIE | Q2 | — | 7/14 |
| 2011 | TOXICOLOGY | SCIE | Q2 | — | 39/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 117/252 |
| 2010 | SUBSTANCE ABUSE | SCIE | Q2 | — | 6/14 |
| 2010 | TOXICOLOGY | SCIE | Q2 | — | 36/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 115/237 |
| 2009 | SUBSTANCE ABUSE | SCIE | Q2 | — | 5/11 |
| 2009 | TOXICOLOGY | SCIE | Q2 | — | 35/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 104/219 |
| 2008 | SUBSTANCE ABUSE | SCIE | Q2 | — | 5/11 |
| 2008 | TOXICOLOGY | SCIE | Q2 | — | 31/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 100/205 |
| 2007 | SUBSTANCE ABUSE | SCIE | Q2 | — | 5/10 |
| 2007 | TOXICOLOGY | SCIE | Q2 | — | 30/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 99/199 |
| 2006 | SUBSTANCE ABUSE | SCIE | Q3 | — | 5/8 |
| 2006 | TOXICOLOGY | SCIE | Q2 | — | 32/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/193 |
| 2005 | SUBSTANCE ABUSE | SCIE | Q3 | — | 6/8 |
| 2005 | TOXICOLOGY | SCIE | Q2 | — | 37/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/187 |
| 2004 | SUBSTANCE ABUSE | SCIE | Q3 | — | 5/8 |
| 2004 | TOXICOLOGY | SCIE | Q2 | — | 28/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 97/185 |
| 2003 | SUBSTANCE ABUSE | SCIE | Q4 | — | 7/9 |
| 2003 | TOXICOLOGY | SCIE | Q2 | — | 36/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/188 |
| 2002 | SUBSTANCE ABUSE | SCIE | Q3 | — | 6/9 |
| 2002 | TOXICOLOGY | SCIE | Q2 | — | 25/76 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 100/186 |
| 2001 | SUBSTANCE ABUSE | SCIE | Q3 | — | 6/9 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 38/78 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/181 |
| 2000 | SUBSTANCE ABUSE | SCIE | Q3 | — | 5/9 |
| 2000 | TOXICOLOGY | SCIE | Q2 | — | 28/77 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/175 |
| 1999 | SUBSTANCE ABUSE | SCIE | Q3 | — | 6/9 |
| 1999 | TOXICOLOGY | SCIE | Q2 | — | 24/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/178 |
| 1998 | SUBSTANCE ABUSE | SCIE | Q3 | — | 6/9 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 25/71 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 73/157 |
| 1997 | SUBSTANCE ABUSE | SCIE | Q4 | — | 7/9 |
| 1997 | TOXICOLOGY | SCIE | Q2 | — | 22/63 |